Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-25

FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA has approved a supplemental application for NOVOLOG (insulin aspart) from Novo Nordisk. The approval relates to changes to the product's labeling and/or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NovoLog (insulin aspart)

Snippet

SUPPL AP for NOVOLOG (INSULIN ASPART)